Trial aims to extend remission for children treated with T-cell immunotherapy for leukemia
After phase 1 results of Seattle Children's Pediatric Leukemia Adoptive Therapy (PLAT-02) trial have shown T-cell immunotherapy to be effective in getting 93 percent of patients with relapsed or refractory acute lymphoblastic ...
May 9, 2017